Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) This study is currently recruiting participants. Purpose This trial examines the way flibanserin is metabolized in postmenopausal women with Hypoactive Sexual Desire Disorder. Condition Intervention Phase Sexual Dysfunctions, Psychological Drug: flibanserin drug Phase I Sponsor: Boehringer Ingelheim Pharmaceuticals Information provided by: Boehringer...
There are so many kinds of cases for the Apple iPad. Which one is the best? Which one is the right one for you?...